Center for Inherited Disease Research (CIDR) High Throughput Sequencing and Genotyping Resource Access (X01 Clinical Trial Not Allowed)
This grant provides access to advanced genotyping, sequencing, and statistical genetics services at CIDR to help researchers study genetic contributions to human health and disease.
Funder: National Institutes of Health
Due Dates (Anticipated): September 2026 (projected)
Funding Amounts: No specified ceiling or floor; access to high-throughput sequencing/genotyping services, not direct monetary awards.
Summary: Provides access to advanced sequencing, genotyping, and statistical genetics services for research on inherited diseases and human health.
Key Information: This is a forecasted opportunity; dates and details may change upon official announcement.
Description
This NIH-wide initiative provides researchers with access to the Center for Inherited Disease Research (CIDR), which offers high-throughput genotyping, sequencing, and statistical genetics services. The goal is to facilitate the identification of genes or genetic modifications contributing to human health and disease, and to enhance the classification of well-phenotyped specimens with genotype or next-generation sequence data. CIDR specializes in large-scale genomic services that are not feasible for most individual labs, utilizing state-of-the-art platforms and expert support. The program is administered by the National Human Genome Research Institute (NHGRI).
